CD14 and Stroke: In stroke, CD14++ CD16− DR+ monocytes were also higher in patients with systemic axonal injury, early worsening, poor prognosis, and early mortality, indicating that monitoring of monocyte subtypes may represent a useful tool for predicting clinical course and prognosis in stroke patients (26).